Literature DB >> 31602628

Upregulation of Intestinal NLRP6 Inflammasomes After Roux-en-Y Gastric Bypass Promotes Gut Immune Homeostasis.

Geng Wang1, Qingbo Wang1,2, Jie Bai1, Ning Zhao1, Yu Wang1, Rui Zhou3, Wen Kong4, Tianshu Zeng4, Kaixiong Tao1, Guobin Wang1, Zefeng Xia5.   

Abstract

OBJECTIVE: Roux-en-Y gastric bypass (RYGB) could affect immunological activity after surgery. We examined the role of RYGB on the NOD-like receptor pyrin domain containing-6 (NLRP6) in the intestine after surgery in rat models.
METHODS: Expression of intestinal NLRP6 in the lean, obesity, RYGB, and sham-pair fed (PF) groups was analyzed by quantitative RT-PCR, Western blotting, and immunohistochemistry. Gut microbiota abundance was determined by 16S rRNA sequencing. Cohousing experiments were conducted to analyze the effects of gut microbiota. Inflammatory cell infiltration and gut permeability were further validated.
RESULTS: Obese rats had decreased intestinal NLRP6 levels, which could be restored by RYGB but not by calorie restriction. This regulation was dependent on the gut microbiota-related metabolites, taurine, and histamine. After RYGB, there were increased levels of taurine, which could positively affect NLRP6 expression. The pair-fed groups showed increased histamine, which had the opposite effects on NLRP6. Obese rats had greater intestinal permeability along with increased CD8+ T cell infiltration. However, RYGB but not calorie restriction could restore these changes in a manner, dependent on gut NLRP6 expression.
CONCLUSIONS: In rat models, RYGB could efficiently restore abnormal gut permeability and reduce inflammation in the intestine, depending on reactivation of NLRP6.

Entities:  

Keywords:  Gut microbiota; Inflammasome; Metabolite; NLRP6; RYGB

Year:  2020        PMID: 31602628     DOI: 10.1007/s11695-019-04152-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  33 in total

Review 1.  Obesity, inflammation, and the gut microbiota.

Authors:  Amanda J Cox; Nicholas P West; Allan W Cripps
Journal:  Lancet Diabetes Endocrinol       Date:  2014-07-22       Impact factor: 32.069

2.  Optimization of a Technique to Standardize the Rodent Roux-En-Y Gastric Bypass Model and Troubleshooting of Postoperative Failures.

Authors:  Qingbo Wang; Geng Wang; Chaojie Hu; Jinpeng Du; Jie Bai; Miaomiao Peng; Ning Zhao; Yu Wang; Kaixiong Tao; Guobin Wang; Zefeng Xia
Journal:  Obes Surg       Date:  2019-05       Impact factor: 4.129

3.  Sleeve Gastrectomy Does Not Cause Hypertrophy and Reprogramming of Intestinal Glucose Metabolism in Rats.

Authors:  Michael B Mumphrey; Zheng Hao; R Leigh Townsend; Laurel M Patterson; Hans-Rudolf Berthoud
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

4.  Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity.

Authors:  Bárbara Dal Molin Netto; Solange Cravo Bettini; Ana Paula Grotti Clemente; Joana Pereira de Carvalho Ferreira; Katia Boritza; Sandy de Fátima Souza; Maria Emilia Von der Heyde; Carrie P Earthman; Ana R Dâmaso
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

5.  Influence of bariatric surgery on the expression of nesfatin-1 in rats with type 2 diabetes mellitus.

Authors:  Zefeng Xia; Geng Wang; Huiqing Li; Chaojie Hu; Qingbo Wang; Anshu Li; Ende Zhao; Xiaoming Shuai; Jiliang Wang; Kailin Cai; Kaixiong Tao; Guobin Wang
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury.

Authors:  Sylvain Normand; Anne Delanoye-Crespin; Aude Bressenot; Ludovic Huot; Teddy Grandjean; Laurent Peyrin-Biroulet; Yves Lemoine; David Hot; Mathias Chamaillard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-18       Impact factor: 11.205

7.  Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes.

Authors:  Yan Guo; Chao-Qian Liu; Cheng-Xiang Shan; Yue Chen; Hui-Hua Li; Zhi-Ping Huang; Da-Jin Zou
Journal:  Diabetes Metab Res Rev       Date:  2016-11-08       Impact factor: 4.876

8.  Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.

Authors:  Tatsuya Sasaki; Keyue Liu; Takashi Agari; Takao Yasuhara; Jun Morimoto; Mihoko Okazaki; Hayato Takeuchi; Atsuhiko Toyoshima; Susumu Sasada; Aiko Shinko; Akihiko Kondo; Masahiro Kameda; Ikuko Miyazaki; Masato Asanuma; Cesario V Borlongan; Masahiro Nishibori; Isao Date
Journal:  Exp Neurol       Date:  2015-11-10       Impact factor: 5.330

9.  NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens.

Authors:  Paras K Anand; R K Subbarao Malireddi; John R Lukens; Peter Vogel; John Bertin; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

10.  NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion.

Authors:  Marta Wlodarska; Christoph A Thaiss; Roni Nowarski; Jorge Henao-Mejia; Jian-Ping Zhang; Eric M Brown; Gad Frankel; Maayan Levy; Meirav N Katz; William M Philbrick; Eran Elinav; B Brett Finlay; Richard A Flavell
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

View more
  7 in total

1.  Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR.

Authors:  Mohammed K Hankir; Theresa Langseder; Ezgi Eyluel Bankoglu; Yalda Ghoreishi; Ulrich Dischinger; Max Kurlbaum; Matthias Kroiss; Christoph Otto; Carel W le Roux; Tulika Arora; Florian Seyfried; Nicolas Schlegel
Journal:  iScience       Date:  2020-11-05

Review 2.  Metabolic regulators of enigmatic inflammasomes in autoimmune diseases and crosstalk with innate immune receptors.

Authors:  Gisela Jimenez-Duran; Martha Triantafilou
Journal:  Immunology       Date:  2021-05-02       Impact factor: 7.397

3.  2'-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression.

Authors:  Qianqian Yao; Linlin Fan; Nan Zheng; Christophe Blecker; Véronique Delcenserie; Huiying Li; Jiaqi Wang
Journal:  Front Nutr       Date:  2022-02-17

4.  Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations.

Authors:  Laimdota Zizmare; Christina N Boyle; Sabrina Buss; Sandrine Louis; Laura Kuebler; Ketki Mulay; Ralf Krüger; Lara Steinhauer; Isabelle Mack; Manuel Rodriguez Gomez; Kristina Herfert; Yvonne Ritze; Christoph Trautwein
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

5.  The Differential Expression of the Inflammasomes in Adipose Tissue and Colon Influences the Development of Colon Cancer in a Context of Obesity by Regulating Intestinal Inflammation.

Authors:  Gema Frühbeck; Amaia Mentxaka; Patricia Ahechu; Javier Gómez-Ambrosi; Beatriz Ramírez; Sara Becerril; Amaia Rodríguez; Xabier Unamuno; Javier A Cienfuegos; Marcos Casado; María A Burrell; Marina Martín; Jorge Baixauli; Victor Valentí; Rafael Moncada; Gabriel Reina; Camilo Silva; Victoria Catalán
Journal:  J Inflamm Res       Date:  2021-12-01

6.  Leaky Gut as a Potential Culprit for the Paradoxical Dysglycemic Response to Gastric Bypass-Associated Ileal Microbiota.

Authors:  Mohammed K Hankir; Florian Seyfried; Isabel N Schellinger; Nicolas Schlegel; Tulika Arora
Journal:  Metabolites       Date:  2021-03-08

7.  Metabolic surgery in China: present and future.

Authors:  Yinfang Tu; Yuqian Bao; Pin Zhang
Journal:  J Mol Cell Biol       Date:  2021-07-07       Impact factor: 6.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.